Topical Cyclosporine and Disease Progression
Completed · Phase 4
Conditions studied: Disease Progression, Disease Severity, Staining, Schirmers, OSDI
In brief
The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.
Key facts
- Study ID
- NCT00567983
- Run by
- Innovative Medical
- People needed
- 80
- Starts
- 2007-12-01
- Expected to finish
- 2008-09-01
- Last updated by the study team
- 2008-09-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Mild to Moderate dry eye symptoms
You may not qualify if…
- Current use of Restasis
Where it is running
- Lakeside Eye Clinic — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.